Does Rhode Island Medicaid cover Wegovy or Zepbound?
Last updated
No: Rhode Island Medicaid stopped covering Wegovy and Zepbound for weight loss alone on Oct 1, 2026.
Without Medicaid: the lowest cash prices in Rhode Island

Lowest compounded semaglutide in Rhode Island on a monthly plan, not FDA-approved
$59/mo + $199/yr membership · about $29 less over a year than Sunlight, membership included · first order: membership free for the first 21 days, never charged if you cancel before

Next lowest per 30 days, supply stated: compounded semaglutide in Rhode Island
$78/mo · ≈ $84 per 30 days

Lowest compounded tirzepatide in Rhode Island on a monthly plan, not FDA-approved
$69/mo + $199/yr membership · about $389 less over a year than FlatRx, membership included · first order: membership free for the first 21 days, never charged if you cancel before

Next lowest per 30 days, supply stated: compounded tirzepatide in Rhode Island
$129/mo · ≈ $138 per 30 days
- F

Lowest compounded liraglutide in Rhode Island on a monthly plan, not FDA-approved
$408.99/4 weeks

No. Rhode Island Medicaid stopped covering Wegovy and Zepbound for weight loss alone on Oct 1, 2026. The state's notice: "beginning October 1, 2026, Rhode Island Medicaid will no longer cover certain GLP-1 receptor agonists when they are prescribed solely for weight loss." It names Foundayo (orforglipron), Saxenda (liraglutide), Wegovy (semaglutide) and Zepbound (tirzepatide). (Rhode Island EOHHS memorandum, August 5, 2026, eohhs.ri.gov, read Nov 17, 2026). Every program must still cover some uses: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively" (KFF, Medicaid Coverage of and Spending on GLP-1s (January 2026), kff.org/medicaid/medicaid-coverage-of-and-spending-on-glp-1s, read Nov 17, 2026). Paying cash in Rhode Island, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year) and compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year). Compounded medicines are not FDA-approved.
Rhode Island Medicaid and GLP-1s: common questions
Does Rhode Island Medicaid cover Wegovy?
For weight loss alone, no: Rhode Island Medicaid stopped covering Wegovy and Zepbound for weight loss alone on Oct 1, 2026. Every Medicaid program must cover Wegovy for the treatment of cardiovascular disease, KFF notes, with the state's own criteria. Wegovy not covered: the cash price at your dose
Does Rhode Island Medicaid cover Zepbound?
For weight loss alone, no: Rhode Island Medicaid stopped covering Wegovy and Zepbound for weight loss alone on Oct 1, 2026. Every Medicaid program must cover Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, KFF notes, with the state's own criteria. Zepbound not covered: the cash price at your dose
Does Rhode Island Medicaid cover Ozempic or Mounjaro?
For type 2 diabetes, yes: in KFF's words, "coverage of GLP-1 drugs for the treatment of obesity remains optional for states, while coverage is required for drugs approved for the treatment of diabetes and, since March 2024 and December 2024, for the treatment of cardiovascular disease (Wegovy) and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound), respectively." Ozempic and Mounjaro are approved for type 2 diabetes. For weight loss alone, no: Rhode Island Medicaid stopped covering Wegovy and Zepbound for weight loss alone on Oct 1, 2026.
How much do Wegovy and Zepbound alternatives cost in Rhode Island without Medicaid?
Paying cash in Rhode Island, the lowest on a monthly plan at sellers whose own pages say they serve the state: compounded semaglutide from $59/mo + $199/yr membership at Collective (about $76 a month over a year) and compounded tirzepatide from $69/mo + $199/yr membership at Collective (about $86 a month over a year). Compounded medicines are not FDA-approved. Semaglutide: advertised as $59/mo + $199/yr membership at Collective, checked Nov 15, 2026 on collective.org. Tirzepatide: advertised as $69/mo + $199/yr membership at Collective, checked Nov 15, 2026 on collective.org. Liraglutide: advertised as $408.99/4 weeks at NuBloom, checked Nov 14, 2026 on mynubloom.com. Every compounded price in Rhode Island
Which states' Medicaid covers GLP-1s for weight loss?
10 programs, by KFF's January 2026 map and the states' own notices since: Delaware, Kansas, Michigan, Minnesota, Mississippi, Missouri, North Carolina, Tennessee, Virginia, and Wisconsin. Every state's Medicaid and GLP-1s
What Rhode Island Medicaid paid for
From Q2 2025 to Q1 2026, Rhode Island's Medicaid program reported 48,566 GLP-1 prescriptions to CMS, 14,270 of them for brands approved for weight management (Wegovy, Zepbound and Saxenda), which ranks 18 among the states on those brands. A paid prescription does not say what it was prescribed for. Every state's prescriptions
GLPcompare links out only to sellers with a referral program: if you sign up or buy through one of those links, we may earn a commission at no extra cost to you. For other sellers we show the price and the seller's address, and suggest sellers we can link to. It never changes the price you pay or the underlying data. Our default order is lowest price first, with sellers that pay us moved up, and the note under each list says which order it shows; every lowest-cost sort uses the price alone. In a price table, a partner's offer says so in its terms. The order is not a medical recommendation; a higher-placed offer is not necessarily the lowest price or the right product for you.